Кривое зеркало жизни. Главные мифы о раке, и что современная наука думает о них

Gaggioli C., Hooper S., Hidalgo-Carcedo C., Grosse R., Marshall J. F., Harrington K., Sahai E. Fibroblast-led collective invasion of carcinoma cells with differing roles for RhoGTPases in leading and following cells // Nature Cell Biology, 2007, 9 (12), 1392–1400.

Kalluri R. The biology and function of fibroblasts in cancer // Nature Reviews Cancer, 2016, 16 (9), 582–598.

Kaplan R. N., Riba R. D., Zacharoulis S., Bramley A. H. & others. VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche // Nature, 2005, 438 (7069), 820–827.

Kessenbrock K., Plaks V., Werb Z. Matrix metalloproteinases: regulators of the tumor microenvironment // Cell, 2010, 141 (1), 52–67.

Mantovani A., Allavena P., Sica A., Balkwill F. Cancer-related inflammation // Nature, 2008, 454 (7203), 436–444.

Nelson C. M., Bissell M. J. Of extracellular matrix, scaffolds, and signaling: tissue architecture regulates development, homeostasis, and cancer // Annual Review of Cell and Developmental Biology, 2006, 22, 287–309.

Pachmayr E., Treese C., Stein U. Underlying Mechanisms for Distant Metastasis — Molecular Biology // Visceral Medicine, 2017, 33 (1), 11–20.

Peinado H., Lavotshkin S., Lyden D. The secreted factors responsible for pre-metastatic niche formation: old sayings and new thoughts // Seminars in Cancer Biology, 2011, 21 (2), 139–146.

Rich R. M., Rosenfeld P. J., Puliafito C. A., Dubovy S. R. & others. Short-term safety and efficacy of intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration // Retina, 2006, 26 (5), 495–511.

Yang J., Weinberg R. A. Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis // Developmental Cell, 2008, 14 (6), 818–829.

Глава 7. Тонкости распознавания «свой-чужой» и мифы об иммунитете

Терапевтические антитела. Спецпроект электронного журнала «Биомолекула». https://biomolecula.ru/specials/antitela.

Ярилин А. А. Иммунология. — М.: ГЭОТАР-Медиа, 2010.

Blum J. S., Wearsch P. A., Cresswell P. Pathways of antigen processing // Annual Review of Immunology, 2013, 31, 443–473.

Bottazzi B., Riboli E., Mantovani A. Aging, inflammation and cancer // Seminars in Immunology, 2018, 40, 74–82.

June C. H., O’Connor R. S., Kawalekar O. U., Ghassemi S., Milone M. C. CAR T cell immunotherapy for human cancer // Science, 2018, 359 (6382), 1361–1365.

Kucerova P., Cervinkova M. Spontaneous regression of tumour and the role of microbial infection — possibilities for cancer treatment // Anticancer Drugs, 2016, 27 (4), 269–277.

Liu J. K. The history of monoclonal antibody development — Progress, remaining challenges and future innovations // Annals of Medicine and Surgery (Lond), 2014, 3 (4), 113–116.

Mantovani A., Sica A. Macrophages, innate immunity and cancer: balance, tolerance, and diversity // Current Opinion in Immunology, 2010, 22 (2), 231–237.

Murchison E. P. Clonally transmissible cancers in dogs and Tasmanian devils // Oncogene, 2008, 27, 19–30. Papac R. J. Spontaneous regression of cancer // Cancer Treatment Reviews, 1996, 22 (6), 395–423.

Murgia C., Pritchard J. K., Kim S. Y., Fassati A., Weiss R. A. Clonal origin and evolution of a transmissible cancer // Cell, 2006, 126 (3), 477–487.

Pardoll D. M. The blockade of immune checkpoints in cancer immunotherapy // Nature Reviews Cancer, 2012, 12 (4), 252–264.

Rashidi A., Fisher S. I. Spontaneous remission of acute myeloid leukemia // Leukemia & Lymphoma, 2015, 56 (6), 1727–1734.

Reeves E., James E. Antigen processing and immune regulation in the response to tumours // Immunology, 2017, 150 (1), 16–24.

Schreiber R. D., Old L. J., Smyth M. J. Cancer immunoediting: integrating immunity’s roles in cancer suppression and promotion // Science, 2011, 331 (6024), 1565–1570.